Daohai Du

Title: **Daohai Du: Innovator in Triazolopyrimidine Compounds**

Introduction

Daohai Du is an accomplished inventor based in Shanghai, China, known for his significant contributions to the field of medicinal chemistry. With a focus on developing innovative compounds, Du has made strides in treating diseases mediated by EED and/or PRC2.

Latest Patents

Du holds a patent for "Triazolopyrimidine, triazolopyridine compounds, and the composition thereof for treating PRC2-mediated diseases." This invention encompasses a compound represented by formula I, along with its pharmaceutically acceptable salts, enantiomers, diastereomers, or racemates. The patent outlines the preparation method, the corresponding pharmaceutical composition, and its application in the development of medicaments aimed at treating ailments influenced by PRC2.

Career Highlights

Throughout his career, Daohai Du has worked with notable institutions such as the Shanghai Institute of Materia Medica, affiliated with the Chinese Academy of Sciences, and Suzhou Suplead Life Sciences Co., Ltd. His work in these organizations has been integral in furthering medical research and innovation.

Collaborations

Du's research efforts have involved collaborations with esteemed colleagues, including Bing Zhou and Cheng Luo. These partnerships have played a crucial role in advancing his projects and patent achievements.

Conclusion

Daohai Du stands out as a prominent figure in the realm of drug development, specifically in the creation of compounds for PRC2-mediated diseases. His expertise and collaborative spirit foster significant advancements in pharmaceutical science, demonstrating the impact of innovation in healthcare.